Effective and Safe Treatment of Risky Localized Liver Tumors Using Microwave Ablation in Patients with Comorbid Lung Diseases Unfit for Deep Anesthesia
Objective: To assess the safety and efficacy of percutaneous microwave ablation (MWA) in treating high-risk localized liver tumors in patients unable to undergo deep anesthesia because of comorbid lung diseases. Methods: Between January 2019 and January 2022, percutaneous MWA procedures were perform...
Saved in:
Main Author: | Murat ASIK |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-03-01
|
Series: | Medeniyet Medical Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-54358 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01) -
Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status
by: Xuxiazi Zou, et al.
Published: (2025-02-01) -
The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
by: Wenhui Wang, et al.
Published: (2025-01-01) -
Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
by: Gui-Lin Xie, et al.
Published: (2025-01-01) -
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study
by: Alizée Renan, et al.
Published: (2025-02-01)